Skip to main navigation Skip to search Skip to main content

A Pilot, Phase IIB, Randomized, Multi-Center Trial of Argatroban in Combination with Recombinant Tissue Plasminogen Activator for Acute Stroke (ARTSS-2)

SUNY Downstate Health Sciences University

Project: Research

Project Details

StatusFinished
Effective start/end date03/1/13 → 06/30/16

Funding

  • University of Texas Health Science Center at Houston: $37,093.00